Zhang, Ye <br/><br/>
Telbivudine plus adefovir therapy for chronic hepatitis B patients with virological breakthrough or genotypic resistance to telbivudine.  [electronic resource] 

 -  European journal of gastroenterology & hepatology  Jul 2013 
 - 814-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5687 
<br/><br/><label>Standard No.: </label>10.1097/MEG.0b013e32835ee516  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--adverse effects<br/>Antiviral Agents--adverse effects<br/>Biomarkers--blood<br/>Chi-Square Distribution<br/>DNA, Viral--blood<br/>Drug Resistance, Viral--genetics<br/>Drug Therapy, Combination<br/>Genotype<br/>Hepatitis B e Antigens--blood<br/>Hepatitis B virus--drug effects<br/>Hepatitis B, Chronic--diagnosis<br/>Humans<br/>Organophosphonates--adverse effects<br/>Phenotype<br/>Telbivudine<br/>Thymidine--adverse effects<br/>Time Factors<br/>Treatment Outcome<br/>Viral Load<br/>Virus Replication--drug effects